$80.00
In stock
Glow 70 is a high-purity, lyophilized laboratory research material formulated as a 70 mg tri-compound blend. It combines three well-characterized research compounds — GHK-Cu (Copper Tripeptide-1), BPC-157, and TB-500 (Thymosin Beta-4 Fragment) — in a single preparation. This multi-compound format is of interest to researchers investigating the concurrent activity of copper-binding signaling molecules, actin-regulatory fragments, and cytoprotective sequences in controlled in vitro and pre-clinical laboratory settings.
Each constituent of this research material has an independent history of scientific investigation. GHK-Cu has been studied extensively in the context of fibroblast activity, collagen-related gene expression, and oxidative stress modulation in cell culture and pre-clinical models. BPC-157, a 15-amino-acid sequence derived from a gastric protein, has been investigated in pre-clinical research for its associations with angiogenic signaling, cell migration, and connective tissue modeling. TB-500, a synthetic fragment of Thymosin Beta-4, has been explored for its role in actin-binding dynamics, cytoskeletal organization, and anti-fibrotic pathways in laboratory research contexts. Scientific inquiry into the potential interactions among these three compounds — particularly across copper-peptide signaling, vascular modeling, and structural protein regulation — represents an active area of pre-clinical interest.
GHK-Cu is a copper-complexed tripeptide that has been investigated for its capacity to modulate collagen synthesis and fibroblast recruitment in tissue culture models. BPC-157 is a 15-amino-acid research compound that has been studied in relation to angiogenesis and cellular migration mechanisms in pre-clinical models. TB-500 is structurally characterized by its actin-binding domain and has been investigated for its involvement in cytoskeletal organization and tissue remodeling pathways. The combination of these three structurally distinct research compounds in a single lyophilized preparation is intended to facilitate research into their concurrent or interactive mechanistic profiles within a controlled laboratory environment.
Glow 70 is intended exclusively for laboratory and in vitro research purposes. This material is not intended for human or veterinary use of any kind. It is not a drug, supplement, food product, or medical device, and no claims are made regarding its safety, efficacy, or suitability for administration to humans or animals. All handling should be performed by qualified research personnel in compliance with applicable institutional and regulatory guidelines.